Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.96 USD | -3.86% | -9.88% | -30.29% |
Apr. 09 | UBS Adjusts Denali Therapeutics Price Target to $32 From $70, Maintains Buy Rating | MT |
Apr. 03 | Denali Therapeutics Insider Sold Shares Worth $1,896,250, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.29% | 2.13B | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.67% | 22.02B | |
-17.84% | 20.9B | |
-9.19% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- DNLI Stock
- News Denali Therapeutics Inc.
- Insider Trends: Insider Adds to Selling Trend at Denali Therapeutics